SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BioAdaptives, Inc. (BDPT) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 12/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BDPT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio14.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.06
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.02 |
$0.00 |
$-227.43K |
- |
| 2016 |
$-0.01 |
$19.04K |
$-171.35K |
-899.7% |
| 2017 |
$0.00 |
$0.00 |
$-62.5K |
- |
| 2018 |
$-0.08 |
$0.00 |
$-1.41M |
- |
| 2019 |
$-0.01 |
$9.93K |
$-239K |
-2405.9% |
| 2020 |
$-0.04 |
$16.33K |
$-847K |
-5187.7% |
| 2021 |
$-4.50 |
$19.78K |
$-1.05M |
-5309.5% |
| 2022 |
$-1.50 |
$17.18K |
$-896K |
-5216.6% |
| 2023 |
$0.00 |
$28.57K |
$-712K |
-2492.6% |
| 2024 |
$-0.06 |
$12.67K |
$-899K |
-7096.1% |
